Biologics/Immunotherapy News

ORLANDO — Two toddlers who had peanut allergy during infancy are now able to safely consume peanuts following a new protocol, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

CHICAGO — Omalizumab had the greatest risk for adverse effects and dupilumab had the most favorable safety profile among biologics for patients with asthma, according to an abstract presented at the CHEST Annual Meeting.

CHICAGO — Patients with asthma who experience hypersensitivity reactions to multiple biologics may benefit from allergist evaluations and desensitization, according to a poster presented at the CHEST Annual Meeting.

CHICAGO — Patients who depended on oral corticosteroids to care for their severe asthma experienced improvements in asthma control after initiating treatment with tezepelumab, according to an abstract presented at CHEST 2025.

Ethical and statistical power issues limit the use of randomized controlled trials to study medication and vaccine use during pregnancy, according to an article published in The Journal of Allergy and Clinical Immunology: In Practice.

Two doses of verekitug improved symptoms for patients with chronic rhinosinusitis with nasal polyps compared with placebo through 24 weeks, according to data presented during a corporate webinar.

In these videos, Douglas H. Jones, MD, the medical director and CEO of Global Allergy Immune Network, discusses the latest developments in the treatment and of hereditary angioedema.

In these videos, Douglas H. Jones, MD, the medical director and CEO of Global Allergy Immune Network, discusses the latest developments in the treatment and of hereditary angioedema.

In these videos, Douglas H. Jones, MD, the medical director and CEO of Global Allergy Immune Network, discusses the latest developments in the treatment and of hereditary angioedema.

In these videos, Douglas H. Jones, MD, the medical director and CEO of Global Allergy Immune Network, discusses the latest developments in the treatment and of hereditary angioedema.